Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia

[1]  W. Dauer,et al.  Primary dystonia: molecules and mechanisms , 2009, Nature Reviews Neurology.

[2]  G. Bernardi,et al.  Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. , 2009, Brain : a journal of neurology.

[3]  V. Dhawan,et al.  Abnormal striatal and thalamic dopamine neurotransmission , 2009, Neurology.

[4]  G. Bernardi,et al.  Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia , 2009, Neurobiology of Disease.

[5]  P. Gubellini,et al.  Role of glutamate transporters in corticostriatal synaptic transmission , 2009, Neuroscience.

[6]  D. Centonze,et al.  d-Aspartate Prevents Corticostriatal Long-Term Depression and Attenuates Schizophrenia-Like Symptoms Induced by Amphetamine and MK-801 , 2008, The Journal of Neuroscience.

[7]  P. Greengard,et al.  Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity , 2008, Science.

[8]  T. Wichmann.  Commentary: Dopaminergic dysfunction in DYT1 dystonia , 2008, Experimental Neurology.

[9]  D. James Surmeier,et al.  Corticostriatal and Thalamostriatal Synapses Have Distinctive Properties , 2008, The Journal of Neuroscience.

[10]  M. LeDoux,et al.  Abnormal motor function and dopamine neurotransmission in DYT1 ΔGAG transgenic mice , 2008, Experimental Neurology.

[11]  M. Hallett,et al.  The pathophysiological basis of dystonias , 2008, Nature Reviews Neuroscience.

[12]  G. Fisone,et al.  Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons , 2007, Neuroscience & Biobehavioral Reviews.

[13]  J. Donoghue,et al.  Plasticity of the synaptic modification range. , 2007, Journal of neurophysiology.

[14]  M. Morelli,et al.  Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications , 2007, Progress in Neurobiology.

[15]  X. Breakefield,et al.  Dopamine release is impaired in a mouse model of DYT1 dystonia , 2007, Journal of neurochemistry.

[16]  Douglas R. Porter,et al.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice , 2007, Proceedings of the National Academy of Sciences.

[17]  R. Lefkowitz,et al.  β-Arrestins and Cell Signaling , 2007 .

[18]  Robert C. Malenka,et al.  Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models , 2007, Nature.

[19]  R. Huganir,et al.  Synapse-specific regulation of AMPA receptor function by PSD-95 , 2006, Proceedings of the National Academy of Sciences.

[20]  G. Bernardi,et al.  Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia , 2006, Neurobiology of Disease.

[21]  Charles J. Wilson.  Striatal D2 Receptors and LTD: Yes, but Not Where You Thought They Were , 2006, Neuron.

[22]  Henry H. Yin,et al.  Dopaminergic Control of Corticostriatal Long-Term Synaptic Depression in Medium Spiny Neurons Is Mediated by Cholinergic Interneurons , 2006, Neuron.

[23]  M. Baxter,et al.  Impaired Motor Learning in Mice Expressing TorsinA with the DYT1 Dystonia Mutation , 2005, The Journal of Neuroscience.

[24]  P. Calabresi,et al.  Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 , 2005, Neuron.

[25]  V. Dhawan,et al.  Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation , 2005, Neurology.

[26]  G. Fisone,et al.  Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol , 2004, The European journal of neuroscience.

[27]  Hiroshi Kase,et al.  Industry forum: Progress in pursuit of therapeutic A2A antagonists , 2003, Neurology.

[28]  P. Greengard,et al.  Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Augood,et al.  TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion , 2003, Neurobiology of Disease.

[30]  S. Augood,et al.  Dopamine transmission in DYT1 dystonia: A biochemical and autoradiographical study , 2002, Neurology.

[31]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[32]  Alessandro Usiello,et al.  Distinct functions of the two isoforms of dopamine D2 receptors , 2000, Nature.

[33]  S. Kish,et al.  Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation , 2000, Neurology.

[34]  J. Maloteaux,et al.  Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP gamma S binding. , 1999, Life sciences.

[35]  S. Ferré,et al.  Serotonergic agonists behave as partial agonists at the dopamine D2 receptor. , 1999, NeuroReport.

[36]  M. Baik,et al.  Gene expression during involution of mammary gland (review). , 1998, International journal of molecular medicine.

[37]  R. Todd,et al.  Mutational and biochemical analysis of dopamine in dystonia , 1998, Molecular Neurobiology.

[38]  A. Gilman,et al.  Mammalian RGS Proteins: Barbarians at the Gate* , 1998, The Journal of Biological Chemistry.

[39]  K. Black,et al.  MPTP induces dystonia and parkinsonism , 1997, Neurology.

[40]  Sergi Ferré,et al.  Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia , 1997, Trends in Neurosciences.

[41]  N. Risch,et al.  The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein , 1997, Nature Genetics.

[42]  P. Calabresi,et al.  Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. , 1997, Neuroscience.

[43]  P. Calabresi,et al.  Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors , 1997, The Journal of Neuroscience.

[44]  A. Saiardi,et al.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.

[45]  P. Calabresi,et al.  Properties of the Hyperpolarization‐activated Cation Current lh in Rat Midbrain Dopaminergic Neurons , 1995, The European journal of neuroscience.

[46]  D. Lovinger,et al.  Short- and long-term synaptic depression in rat neostriatum. , 1993, Journal of neurophysiology.

[47]  P. Calabresi,et al.  Long-term synaptic depression in the striatum: physiological and pharmacological characterization , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  P. Calabresi,et al.  Long‐term Potentiation in the Striatum is Unmasked by Removing the Voltage‐dependent Magnesium Block of NMDA Receptor Channels , 1992, The European journal of neuroscience.

[49]  E. M. Adler,et al.  Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. , 1992, Brain research. Molecular brain research.

[50]  S. Schiffmann,et al.  Distribution of adenosine A2 receptor mRNA in the human brain , 1991, Neuroscience Letters.

[51]  K. Jacobson,et al.  Characterization of the locomotor depression produced by an A2‐selective adenosine agonist , 1990, FEBS letters.

[52]  N. Mercuri,et al.  Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. , 1987, The Journal of physiology.

[53]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Augood,et al.  Dopamine transmission in DYT1 dystonia. , 2004, Advances in neurology.

[55]  J. Mink,et al.  Dysfunction of dopaminergic pathways in dystonia. , 2004, Advances in neurology.

[56]  S. R. Nash,et al.  Dopamine receptors: from structure to function. , 1998, Physiological reviews.

[57]  D. M. Jackson,et al.  Dopamine receptors: molecular biology, biochemistry and behavioural aspects. , 1994, Pharmacology & therapeutics.